Electrochemical, surface and 1018-steel corrosion product characterization in sulfuric acid with new imidazole-derived inhibitors

Giselle Gómez-Sánchez, Natalya V. Likhanova, Paulina Arellanes-Lozada, Janette Arriola-Morales, Noel Nava, Octavio Olivares-Xometl, Irina V. Lijanova, Grisel Corro

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

In the present work, three imidazole-derived ionic liquids (ILs) were evaluated as corrosion inhibitors (CIs) of AISI 1018 steel in 0.5 and 1.0 M H2SO4. The ILs were: 1-methyl-3-benzylimidazolium chloride (MBIC), 1-methyl-3-hexylimidazolium imidazolate (MIDI) and 1-butyl-3-benzylimidazolium acetate (BBIA). The inhibition efficiency (IE) was calculated from potentiodynamic tests whose results confirmed that the IE of the ILs was directly proportional to the concentration, obtaining the maximal IE (60 %) at 100 ppm with the inhibitor MBIC at 45 °C. The analysis of the electrochemical results revealed that these new ILs displayed the behavior of mixed-type CIs. In addition, the adsorption process of the IL molecules on the steel surface obeyed the Temkin adsorption model. On the other hand, the low IEs were explained through the analysis of electrochemical and thermodynamic parameters (ΔG°ads, ΔH°ads and ΔS°ads). The surface characterization of the samples protected with CIs was carried out by means of the Mössbauer technique, which helped to conclude that the main corrosion products were rozenite, goethite and akaganeite/lepidocrocite. Finally, the corrosion inhibition mechanism performed by the ILs is proposed.

Original languageEnglish
Pages (from-to)9255-9272
Number of pages18
JournalInternational Journal of Electrochemical Science
Volume14
Issue number9
DOIs
StatePublished - 1 Sep 2019

Keywords

  • AISI 1018 carbon steel
  • Electrochemical techniques
  • Ionic liquid
  • Mössbauer
  • Surface analysis

Fingerprint

Dive into the research topics of 'Electrochemical, surface and 1018-steel corrosion product characterization in sulfuric acid with new imidazole-derived inhibitors'. Together they form a unique fingerprint.

Cite this